Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and high-risk prostate cancer

about

Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and high-risk prostate cancer

Item

http://www.wikidata.org/entity/Q41039697

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Long-term outcomes of dose-esc ...... and high-risk prostate cancer

@en

type

Item

label

Long-term outcomes of dose-esc ...... and high-risk prostate cancer

@en

prefLabel

Long-term outcomes of dose-esc ...... and high-risk prostate cancer

@en

P1476

Long-term outcomes of dose-esc ...... and high-risk prostate cancer

@en

P2093

Bernardo Garicochea

http://www.w3.org/2001/XMLSchema#string

Carlos Eduardo Cintra Vita Abreu

http://www.w3.org/2001/XMLSchema#string

Daniel E Spratt

http://www.w3.org/2001/XMLSchema#string

Elton Trigo Teixeira Leite

http://www.w3.org/2001/XMLSchema#string

Fabio Ynoe de Moraes

http://www.w3.org/2001/XMLSchema#string

Fernando Freire Arruda

http://www.w3.org/2001/XMLSchema#string

Heloisa de Andrade Carvalho

http://www.w3.org/2001/XMLSchema#string

Joao Luis Fernandes da Silva

http://www.w3.org/2001/XMLSchema#string

Rafael Gadia

http://www.w3.org/2001/XMLSchema#string

P2860

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients.

Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials.

6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial.

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.

Perineural invasion in cancer: a review of the literature.

NCCN clinical practice guidelines in oncology: prostate cancer.

Outcomes of high-dose intensity-modulated radiotherapy alone with 1 cm planning target volume posterior margin for localized prostate cancer.

High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.

Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect?

Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome.

P304

300-309

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ADRO.2016.10.006

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ana Luiza Bierrenbach

P577

2016-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28740901

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5514229

http://www.w3.org/2001/XMLSchema#string